Paediatric anaesthesia & critical care

Epidemiology, ventilation management, and clinical outcomes in children (PRoVENT-PED): first results from the 10-year, investigator-initiated, international, multicentre, prospective cohort study

Lancet Respir MedPublished Prospective cohort study

Authors' conclusion

Ventilation management in children varies substantially by age and PARDS status. Among potentially modifiable ventilation factors, only PEEP, ΔP, and FiO2 were associated with 28-day mortality.

Study context

Population
Invasively ventilated (≥12 h) critically ill children younger than 18 years in 83 intensive care unit (ICUs) across 34 countries; preterm infants <40 weeks postconceptional age and ECMO excluded
Participants
1,427 participants · 83 ICUs · 34 countries
Exposure
Paediatric acute respiratory distress syndrome (PARDS) vs no PARDS; predefined age groups
  • PARDSn = 164
  • No PARDSn = 1,263reference
Outcome
28-day ICU mortality
Follow-up
28 days
Methodological detailsinvestigator-initiated, international, multicentre, observational, registry, Enrolled April 1 to June 30, 2024, and Oct 1 to Dec 31, 2024
  • Investigator-initiated
  • International
  • Multicentre
  • Observational
  • Registry
  • Enrolled April 1 to June 30, 2024, and Oct 1 to Dec 31, 2024

Main finding

As reported in the abstract

28-day ICU mortality, all children (201 of 1427)
14%
28-day ICU mortality lowest in neonates (3 of 112)
3%

Observational data: associations, not effects.

Further findings

PARDS incidence

PARDS identified in 164 of 1427 children; most frequent in preschool-aged children (3 to <6 years)
11%

Ventilation management

Ventilator management varied by age and PARDS status; decreased age and PARDS associated with exposure to high airway pressures

Modifiable factors associated with ICU mortality

Positive end-expiratory pressure (PEEP), driving pressure (ΔP) and FiO2 independently associated with ICU mortality

Original publication

Epidemiology, ventilation management, and clinical outcomes in children (PRoVENT-PED): first results from the 10-year, investigator-initiated, international, multicentre, prospective cohort study. Lancet Respir Med. Published 1 May 2026. doi:10.1016/s2213-2600(26)00044-5

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.